TrialHaematologica2016

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

Maximilian Merz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.